FDA recommendations to inform psychedelic drug development
Drug Discovery World
JUNE 27, 2023
The US Food and Drug Administration (FDA) has published new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for the potential treatment of medical conditions, including psychiatric or substance use disorders.
Let's personalize your content